Compare TROW & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TROW | WST |
|---|---|---|
| Founded | 1937 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.6B | 20.2B |
| IPO Year | N/A | N/A |
| Metric | TROW | WST |
|---|---|---|
| Price | $104.68 | $277.32 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 11 | 8 |
| Target Price | $106.45 | ★ $345.75 |
| AVG Volume (30 Days) | ★ 1.9M | 696.6K |
| Earning Date | 02-04-2026 | 02-12-2026 |
| Dividend Yield | ★ 4.85% | 0.32% |
| EPS Growth | ★ 0.40 | 0.17 |
| EPS | ★ 9.17 | 6.75 |
| Revenue | ★ $7,205,200,000.00 | $3,017,900,000.00 |
| Revenue This Year | $5.57 | $7.01 |
| Revenue Next Year | $5.59 | $6.20 |
| P/E Ratio | ★ $11.42 | $40.98 |
| Revenue Growth | 4.25 | ★ 4.92 |
| 52 Week Low | $77.85 | $187.43 |
| 52 Week High | $118.32 | $348.90 |
| Indicator | TROW | WST |
|---|---|---|
| Relative Strength Index (RSI) | 54.74 | 54.34 |
| Support Level | $102.58 | $264.92 |
| Resistance Level | $105.20 | $278.43 |
| Average True Range (ATR) | 1.95 | 6.74 |
| MACD | -0.00 | 0.66 |
| Stochastic Oscillator | 59.26 | 65.94 |
T. Rowe Price provides asset management services for individual and institutional investors. It offers a broad range of no-load US and international stock, hybrid, bond, and money market funds. At the end of September, the firm had $1.767 trillion in managed assets, composed of equity (50%), balanced (35%), fixed-income and money market (12%), and alternative (3%) offerings. Approximately two-thirds of managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a US-based asset manager, deriving less than 10% of its AUM from overseas.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.